International Trade Commission February 21, 2018 – Federal Register Recent Federal Regulation Documents

Notice is hereby given that a complaint was filed with the U.S. International Trade Commission on January 11, 2018, under section 337 of the Tariff Act of 1930, as amended, on behalf of 10X Genomics, Inc. of Pleasanton, California. A supplement to the complaint was filed on January 29, 2018. The complaint alleges violations of section 337 based upon the importation into the United States, the sale for importation, and the sale within the United States after importation of certain microfluidic systems and components thereof and products containing same by reason of infringement of U.S. Patent No. 9,644,204 (``the '204 Patent''); U.S. Patent No. 9,689,024 (``the '024 Patent''); U.S. Patent No. 9,695,468 (``the '468 Patent''); and U.S. Patent No. 9,856,530 (``the '530 Patent''). The complaint further alleges that an industry in the United States exists as required by the applicable Federal Statute. The complainant requests that the Commission institute an investigation and, after the investigation, issue a limited exclusion order and a cease and desist order.